Bavarian Nordic A/S (BVNRY)
11.78
+0.30
(+2.61%)
USD |
OTCM |
Oct 09, 16:00
Bavarian Nordic Free Cash Flow (Quarterly) : 46.98M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.98M |
| March 31, 2026 | -126.89M |
| December 31, 2025 | 62.01M |
| September 30, 2025 | 186.71M |
| June 30, 2025 | 64.59M |
| March 31, 2025 | -106.48M |
| December 31, 2024 | 47.29M |
| September 30, 2024 | -68.17M |
| June 30, 2024 | -3.273M |
| March 31, 2024 | 62.38M |
| December 31, 2023 | 49.58M |
| September 30, 2023 | 19.22M |
| June 30, 2023 | 17.60M |
| March 31, 2023 | -65.96M |
| December 31, 2022 | -81.02M |
| September 30, 2022 | -5.448M |
| June 30, 2022 | -34.43M |
| March 31, 2022 | -41.97M |
| December 31, 2021 | -122.36M |
| September 30, 2021 | -7.490M |
| June 30, 2021 | -60.73M |
| March 31, 2021 | -34.86M |
| December 31, 2020 | -135.79M |
| September 30, 2020 | 33.48M |
| June 30, 2020 | 26.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 55.55M |
| December 31, 2019 | -356.13M |
| September 30, 2019 | -21.72M |
| June 30, 2019 | -42.08M |
| March 31, 2019 | -21.85M |
| December 31, 2018 | -11.45M |
| September 30, 2018 | -3.712M |
| June 30, 2018 | -25.12M |
| March 31, 2018 | -38.93M |
| December 31, 2017 | -32.91M |
| September 30, 2017 | -11.65M |
| June 30, 2017 | 42.59M |
| March 31, 2017 | 22.79M |
| December 31, 2016 | 91.46M |
| September 30, 2016 | -36.69M |
| June 30, 2016 | -15.80M |
| March 31, 2016 | -12.80M |
| December 31, 2015 | -29.52M |
| September 30, 2015 | -6.412M |
| June 30, 2015 | -46.35M |
| March 31, 2015 | 89.03M |
| December 31, 2014 | 94.64M |
| September 30, 2014 | -11.29M |
| June 30, 2014 | -21.02M |
| March 31, 2014 | -20.91M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Evaxion AS | -- |
| Genmab A/S | 48.05M |
| Ascendis Pharma A/S | 323.81M |
| Zealand Pharma A/S | 61.68M |
| Agenus, Inc. | -31.20M |